Endocannabinoid enzyme inhibitors had mixed effects on schizophrenia-like symptoms in mice
Low-dose FAAH inhibition improved memory deficits in a mouse schizophrenia model, but higher doses of both FAAH and MAGL inhibitors worsened symptoms.
Quick Facts
What This Study Found
URB 597 (FAAH inhibitor) at 0.3 mg/kg attenuated MK-801-induced memory impairment, but at 1 mg/kg it worsened it. JZL 184 (MAGL inhibitor) at 20-40 mg/kg intensified memory impairment and at 1 mg/kg potentiated hyperlocomotion caused by MK-801.
Key Numbers
URB 597 at 0.3 mg/kg improved memory; at 1 mg/kg it worsened memory. JZL 184 at 20-40 mg/kg worsened memory. JZL 184 at 1 mg/kg increased hyperlocomotion induced by MK-801 at both 0.3 and 0.6 mg/kg.
How They Did This
Mice received MK-801 (NMDA antagonist) to model schizophrenia symptoms, then FAAH inhibitor URB 597 or MAGL inhibitor JZL 184 at various doses. Locomotor activity and passive avoidance memory were measured.
Why This Research Matters
The endocannabinoid system is a potential therapeutic target for schizophrenia, but this study shows the relationship is not straightforward. Dose matters enormously, with low and high doses producing opposite effects.
The Bigger Picture
The biphasic (low dose helps, high dose hurts) pattern seen here mirrors what is often observed with direct cannabinoid agonists. This suggests that fine-tuning endocannabinoid levels, rather than broadly boosting them, may be key to therapeutic benefit.
What This Study Doesn't Tell Us
Mouse model using pharmacological induction of schizophrenia-like symptoms, which may not fully represent human schizophrenia. Only acute (single dose) administration tested. No chronic exposure data.
Questions This Raises
- ?What is the optimal dose window for FAAH inhibition to improve cognitive symptoms?
- ?Would chronic low-dose FAAH inhibition maintain its beneficial effects or lead to tolerance?
Trust & Context
- Key Stat:
- Biphasic dose response
- Evidence Grade:
- Preliminary: single acute-dose mouse study.
- Study Age:
- Published in 2019.
- Original Title:
- Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice.
- Published In:
- Molecular neurobiology, 56(11), 7251-7266 (2019)
- Authors:
- Kruk-Slomka, Marta(2), Banaszkiewicz, Izabela, Slomka, Tomasz, Biala, Grazyna
- Database ID:
- RTHC-02118
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What are FAAH and MAGL inhibitors?
They are enzymes that break down the body's natural endocannabinoids. Inhibiting them raises endocannabinoid levels, which can influence brain function and behavior.
Why did low and high doses have opposite effects?
This biphasic response is common with cannabinoid-related compounds. Low endocannabinoid elevation may restore balance, while too much may overstimulate the system and worsen symptoms.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-02118APA
Kruk-Slomka, Marta; Banaszkiewicz, Izabela; Slomka, Tomasz; Biala, Grazyna. (2019). Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice.. Molecular neurobiology, 56(11), 7251-7266. https://doi.org/10.1007/s12035-019-1596-0
MLA
Kruk-Slomka, Marta, et al. "Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Administration on the Positive and Cognitive Symptoms of Schizophrenia in Mice.." Molecular neurobiology, 2019. https://doi.org/10.1007/s12035-019-1596-0
RethinkTHC
RethinkTHC Research Database. "Effects of Fatty Acid Amide Hydrolase Inhibitors Acute Admin..." RTHC-02118. Retrieved from https://rethinkthc.com/research/kruk-slomka-2019-effects-of-fatty-acid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.